Nutrien rises after Morgan Stanley upgrades US-listed shares to 'overweight'

U.S.-listed shares of Canadian agrichemical company Nutrien NTR.N NTR.TO rise 2.1% to $62.59 premarket

Morgan Stanley upgrades U.S.-listed NTR shares to "overweight" from "equal-weight"

Raises PT to $77 from $70, a 25.6% upside to stock's last close

Expects moderate potash price increases in 2026, with global potash effective capacity utilization rate remaining above 90% until at least 2028

Says higher potash price forecasts push its EBITDA estimate ~12% above consensus

14 out of 24 brokerages rate stock "buy" or higher, 8 "hold" and 2 "sell"; median PT is $66.20 - data compiled by LSEG

In 2025, stock rose 37.9%